Xenon Pharmaceuticals - Common Shares (XENE) closed at $40.48 on November 13, 2026, down 1.3% from the previous close, on volume of 539,029 shares (30-day average 1,377,629).
Data as of November 13, 2026.
13-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 11, 2026 | Call Spread | 21-Jan-2840 : 60 C | 230 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 12, 2026. See the 10 largest for 30, 60 and 90 days
TipRanks (Wed, 11-Nov 5:50 AM ET)
TipRanks (Tue, 10-Nov 11:01 AM ET)
TipRanks (Tue, 10-Nov 8:05 AM ET)
TipRanks (Tue, 10-Nov 8:01 AM ET)
Needham Keeps Their Buy Rating on Xenon (XENE)
TipRanks (Tue, 10-Nov 7:36 AM ET)
Analyst Reiterates Buy on Azetukalner’s Clinical Promise, Maintains $74 Price Target
TipRanks (Tue, 10-Nov 6:55 AM ET)
Analysts Are Bullish on These Healthcare Stocks: Xenon (XENE), Ocular Therapeutix (OCUL)
TipRanks (Tue, 10-Nov 5:40 AM ET)
Xenon Reports Third-Quarter 2026 Results and Business Update
TipRanks (Mon, 9-Nov 5:28 PM ET)
Xenon Pharma GAAP EPS of -$1.11 beats by $0.03
Seeking Alpha News (Mon, 9-Nov 4:31 PM ET)
Xenon Reports Q3 2026 Financial Results and Provides Business Update
Globe Newswire (Mon, 9-Nov 4:01 PM ET)
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Xenon Pharmaceuticals - Common Shares trades on the NASDAQ stock market under the symbol XENE.
As of November 13, 2026, XENE stock price declined to $40.48 with 539,029 million shares trading.
XENE has a beta of 0.26, meaning it tends to be less sensitive to market movements. XENE has a correlation of 0.00 to the broad based SPY ETF.
XENE has a market cap of $3.98 billion. This is considered a Mid Cap stock.
In the last 3 years, XENE traded as high as $72.66 and as low as $26.74.
The top ETF exchange traded funds that XENE belongs to (by Net Assets): IWM, IWO, IBB, TCAF, VTWO.
XENE has underperformed the market in the last year with a return of +1.1%, while the SPY ETF gained +13.4%. In the last 3 month period, XENE fell short of the market, returning -37.0%, while SPY returned -2.8%. However, in the most recent 2 weeks XENE has outperformed the stock market by returning +8.2%, while SPY returned -0.2%.
XENE support price is $39.98 and resistance is $42.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XENE shares will trade within this expected range on the day.
